Greenspring Advisors LLC acquired a new stake in shares of Merck KGaA (OTCMKTS:MKGAF – Free Report) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 7,857 shares of the company’s stock, valued at approximately $1,010,000.
Other institutional investors also recently bought and sold shares of the company. Danske Bank A S purchased a new position in Merck KGaA in the second quarter worth about $276,535,000. Great Lakes Advisors LLC bought a new stake in shares of Merck KGaA during the 2nd quarter valued at about $183,444,000. Tocqueville Asset Management L.P. purchased a new stake in shares of Merck KGaA during the 2nd quarter valued at about $57,546,000. B. Metzler seel. Sohn & Co. AG purchased a new stake in shares of Merck KGaA during the 2nd quarter valued at about $56,952,000. Finally, Edmond DE Rothschild Holding S.A. bought a new position in shares of Merck KGaA in the 2nd quarter worth approximately $51,346,000. Institutional investors own 0.10% of the company’s stock.
Merck KGaA Price Performance
Shares of OTCMKTS:MKGAF opened at $162.12 on Friday. The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27. The stock has a market capitalization of $20.95 billion, a PE ratio of 24.75 and a beta of 0.96. The firm’s 50 day moving average price is $162.47 and its 200-day moving average price is $148.35. Merck KGaA has a twelve month low of $116.68 and a twelve month high of $175.56.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Featured Articles
- Five stocks we like better than Merck KGaA
- 3 Energy Stocks Raising Dividends as the Sector Surges
- 5 Reasons the S&P 500 Could Keep Rallying Through Year-End
- Walmart’s Post-Earnings Drop Could Be a Buying Opportunity
- The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
